The most read articles of january in solaci.org

These were the most read articles of interventional cardiology in solaci.org. Real-World Revascularization Strategy for Left Main Coronary Artery: Surgery or PCI? There are many current randomized trials comparing percutaneous coronary intervention (PCI) with myocardial revascularization surgery (MRS) for the treatment of left main coronary artery disease (LMCAD). Real-World Results of Different Devices for TAVR Transcatheter aortic valve replacement (TAVR) keeps<a href="https://solaci.org/en/2023/02/06/the-most-read-articles-of-january-in-solaci-org/" title="Read more" >...</a>

Manejo quirúrgico o percutáneo de los leaks mitrales

TAVR and New Onset LBBB

The safety and efficacy of transcatheter aortic valve replacement (TAVR) is already established. However, it still poses a challenge for conduction disturbances, such as the need for pacemaker or new onset left bundle branch block (LBBB). The current rate for the latter ranges from approximately 11% to 19%. In most cases, 50% of LBBB reverses<a href="https://solaci.org/en/2023/01/31/tavr-and-new-onset-lbbb/" title="Read more" >...</a>

The Most Important Articles of 2022 in Structural Heart Disease

Discover the most read scientific articles on interventional cardiology of 2022 in our website. We Should Treat Significant Stable CAD in Patients Undergoing TAVR Aortic stenosis is associated to significant coronary artery disease (CAD) in nearly 50% of cases. When we decide to treat aortic disease using surgery, it has been established we should also treat<a href="https://solaci.org/en/2023/01/12/the-most-important-articles-of-2022-in-structural-heart-disease/" title="Read more" >...</a>

Buen desempeño de la Sapien 3 en “trabajos” para los que no está diseñada

Real-World Results of Different Devices for TAVR

Transcatheter aortic valve replacement (TAVR) keeps growing in terms of the development of new devices, more extensive operator experience, and enhanced procedure planning. Nowadays, there are multiple device options, which depend on patient characteristics and operator experience. Two-arm studies compared these devices, analyzing the potential benefits of a certain valve over the others. This multicenter<a href="https://solaci.org/en/2023/01/04/real-world-results-of-different-devices-for-tavr/" title="Read more" >...</a>

Anillos aórticos pequeños, ¿Qué válvula deberíamos elegir?

Clinical Implications of the Presence of HALT in TAVR Patients: 5-Year Follow-Up

The duration of percutaneous aortic valve implants can be increasingly observed over time, regardless of their corresponding surgical risk. In the follow-up of different registries, the presence of subclinical valvular thrombosis, evidenced in tomographic studies as an increase in valvular thickness with hypoattenuation (a term known as HALT), was observed from protocolized images.  This subclinical<a href="https://solaci.org/en/2023/01/03/clinical-implications-of-the-presence-of-halt-in-tavr-patients-5-year-follow-up/" title="Read more" >...</a>

We Should Treat Significant Stable CAD in Patients Undergoing TAVR

Aortic stenosis is associated to significant coronary artery disease (CAD) in nearly 50% of cases.  When we decide to treat aortic disease using surgery, it has been established we should also treat heart disease.  However, when using transcatheter aortic valve replacement (TAVR), this is still unclear, given that in many occasions we see stable lesions<a href="https://solaci.org/en/2022/12/30/we-should-treat-significant-stable-cad-in-patients-undergoing-tavr/" title="Read more" >...</a>

Inflamación crónica, enfermedad coronaria y cáncer: distintas caras de una misma moneda

We Should Start Considering Pulmonary Hypertension After TAVR

Pulmonary hypertension is associated with higher mortality after both aortic valve replacement and transcatheter aortic valve replacement (TAVR). This is a dynamic phenomenon, and what happens after TAVR —during the periprocedure— and its impact are yet to be evaluated. Researchers conducted a subanalysis of the Japanese OCEAN TAVI Registry, which included 1872 patients who were divided<a href="https://solaci.org/en/2022/10/25/we-should-start-considering-pulmonary-hypertension-after-tavr/" title="Read more" >...</a>

Nuevas guías de valvulopatías con actualizaciones clave en TAVI e insuficiencia mitral

SURTAVI at 5 Years

Transcatheter aortic valve replacement (TAVR) by transfemoral access has shown great benefit for different risk groups, but its long-term durability is still uncertain. Available evidence comes from small analysis and a single randomized trial with 280 patients and an 8 year follow-up: the NOTION Trial, where TAVR showed less valvular degeneration than aortic valve replacement (AVR) surgery.<a href="https://solaci.org/en/2022/10/17/surtavi-at-5-years/" title="Read more" >...</a>

La enfermedad vascular periférica se asocia a más eventos en el TAVI

Is Right Ventricle-Pulmonary Artery (RV-PA) Coupling Important in Low Risk TAVR?

TAVR has long been an effective strategy to treat aortic stenosis. However, ventricular damage starts further before symptom onset, also affecting the left ventricle, pulmonary vessels, the right ventricle, the tricuspid valve, and the right atrium.  It increases arterial afterload and uncouples the right ventricle and the pulmonary artery, defined by transthoracic echocardiogram as the relationship<a href="https://solaci.org/en/2022/09/30/is-right-ventricle-pulmonary-artery-rv-pa-coupling-important-in-low-risk-tavr/" title="Read more" >...</a>

TCT 2022 | PROTECTED TAVR

Stroke is still a major complication of transcatheter aortic valve replacement (TAVR), with a 30-day mortality of 16.7%. Even in the absence of symptoms, most patients (68-93%) have some type of diffusion imaging defect after TAVR implantation. The Sentinel cerebral protection device (CPD) (Boston Scientific) received FDA approval for the capture of emboligenic material that<a href="https://solaci.org/en/2022/09/21/tct-2022-protected-tavr-3/" title="Read more" >...</a>